D.E. Shaw & Co
IGMS

D.E. Shaw & Co’s IGM Biosciences IGMS Stock Holding History

D.E. Shaw & Co’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,107
Closed -$61.8K – 4467
2024
Q4 		$61.8K Sell
10,107
-87,609
-90% -$1.04M ﹤0.01% 4195
2024
Q3 		$1.62M Sell
97,716
-33,349
-25% -$365K ﹤0.01% 2882
2024
Q2 		$900K Buy
131,065
+37,902
+41% +$324K ﹤0.01% 3258
2024
Q1 		$899K Buy
93,163
+45,918
+97% +$532K ﹤0.01% 3154
2023
Q4 		$393K Sell
47,245
-28,669
-38% -$166K ﹤0.01% 3626
2023
Q3 		$634K Sell
75,914
-99,672
-57% -$846K ﹤0.01% 3328
2023
Q2 		$1.62M Sell
175,586
-148,951
-46% -$1.67M ﹤0.01% 2769
2023
Q1 		$4.46M Sell
324,537
-65,349
-17% -$1.35M ﹤0.01% 2031
2022
Q4 		$6.63M Buy
389,886
+52,716
+16% +$1.05M 0.01% 1825
2022
Q3 		$7.67M Buy
337,170
+62,616
+23% +$1.26M 0.01% 1604
2022
Q2 		$4.95M Sell
274,554
-111,158
-29% -$1.98M 0.01% 2137
2022
Q1 		$10.3M Buy
385,712
+253,614
+192% +$4.72M 0.01% 1566
2021
Q4 		$3.87M Buy
132,098
+116,413
+742% +$5.78M ﹤0.01% 2663
2021
Q3 		$1.03M Sell
15,685
-11,675
-43% -$893K ﹤0.01% 3579
2021
Q2 		$2.28M Sell
27,360
-28,331
-51% -$2.1M ﹤0.01% 2816
2021
Q1 		$4.27M Buy
55,691
+24,753
+80% +$2.25M ﹤0.01% 1971
2020
Q4 		$2.73M Buy
+30,938
New +$2.17M ﹤0.01% 2345

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

D.E. Shaw & Co's IGMS Position: Q1 2025 in Review

D.E. Shaw & Co sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 10,107 shares — an estimated $61.8K sold.

D.E. Shaw & Co first reported a position in IGMS in Q4 2020 and held it in 17 quarters. The position peaked at $10.3M in Q1 2022. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • D.E. Shaw & Co reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 10,107 IGM Biosciences shares in Q1 2025, an estimated $61.8K.
  • D.E. Shaw & Co first reported a position in IGM Biosciences in Q4 2020 and held it in 17 quarters.
  • D.E. Shaw & Co's IGM Biosciences position peaked at $10.3M in Q1 2022.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.